'%3e%3cpath%20id='s'%20d='M0,162.5%2022.041947,230.338137%20-35.664619,188.411863H35.664619L-22.041947,230.338137z'/%3e%3cuse%20xlink:href='%23s'%20y='-400'/%3e%3cg%20id='s5'%3e%3cuse%20xlink:href='%23s'%20transform='rotate(30)%20rotate(-30,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(60)%20rotate(-60,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(90)%20rotate(-90,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(120)%20rotate(-120,0,200)'/%3e%3cuse%20xlink:href='%23s'%20transform='rotate(150)%20rotate(-150,0,200)'/%3e%3c/g%3e%3cuse%20xlink:href='%23s5'%20transform='scale(-1,1)'/%3e%3c/g%3e%3c/svg%3e)
[EIT- Health]Transformative Healthcare Instrument 2026
The THI is intended to support private companies, specifically Micro, Small and Medium-sized enterprises (SMEs), with at least 4 full-time equivalent employees. Eligible companies must have closed a minimum total equity investment of 2,000,000 EUR within the previous 36-months, with at least one new investor contributing.
Next deadline
Date to be confirmed
What it funds
The THI is intended to support private companies, specifically Micro, Small and Medium-sized enterprises (SMEs), with at least 4 full-time equivalent employees. Eligible companies must have closed a minimum total equity investment of 2,000,000 EUR within the previous 36-months, with at least one new investor contributing.
Who it suits
The THI is intended to support private companies, specifically Micro, Small and Medium-sized enterprises (SMEs), with at least 4 full-time equivalent employees. Eligible companies must have closed a minimum total equity investment of 2,000,000 EUR within the previous 36-months, with at least one ne…
- Life sciences & health
- Industrial R&D
Programme specifications
Considering [EIT- Health]Transformative Healthcare Instrument 2026?
Talk through your project with a specialist and find out whether this is the right competition before you invest time in an application.